Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urachal-sigmoid fistula in an adult male without urachal cyst.

Revista espanola de enfermedades digestivas·2002
Same author

[Extra-articular manifestations of rheumatoid arthritis].

Revista clinica espanola·2000
Same author

[An analysis of calcium pidolate absorption and a comparison with that of a salt in common use, gluconate-lactate-carbonate, in postmenopausal osteoporosis].

Anales de medicina interna (Madrid, Spain : 1984)·1989
Same author

Association of Sjögren's syndrome with psoriatic arthritis.

Canadian Medical Association journal·1984
Same author

[Mixed connective tissue disease with trigeminal sensory neuropathy an unusual serologic evolution].

Medicina clinica·1983
Same author

[Intraalveolar hemorrhage and glomerular nephropathy in the adult: A disease caused by immunocomplexes?].

Revista clinica espanola·1978

Related Experiment Video

Updated: Jul 2, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

Debunking Constipation Myths: What Community Pharmacists Need to Know.

C Díaz López1

  • 1Community Pharmacist in Madrid, Spain. Member of the SEFAC Nutrition and Digestive Health Working Group España.

Farmaceuticos Comunitarios
|July 1, 2026
PubMed
Summary

Common constipation myths, like needing daily bowel movements or laxative addiction, are scientifically unfounded. Pharmacists can combat these misconceptions with evidence-based patient education to improve care.

Keywords:
Constipationcommunity pharmacy serviceshealth education

Related Experiment Videos

Last Updated: Jul 2, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Public Health

Background:

  • Constipation is a widespread gastrointestinal disorder impacting quality of life and healthcare.
  • Management is challenged by persistent myths and beliefs hindering effective treatment.
  • Addressing these misconceptions is crucial for appropriate healthcare intervention.

Purpose of the Study:

  • To identify, analyze, and clarify prevalent myths surrounding constipation.
  • To provide community pharmacists with evidence-based tools for patient education.
  • To enhance clinical practice and improve patient outcomes in constipation management.

Main Methods:

  • A narrative review of scientific literature from 2015-2025.
  • Searches conducted in biomedical databases (PubMed, ScienceDirect, Cochrane) and institutional sources.
  • Inclusion of articles, guidelines, and consensus documents on constipation myths.

Main Results:

  • Identified common misconceptions: daily bowel movement necessity, fluid/olive oil efficacy, laxative harm, gender specificity, and colorectal cancer links.
  • Explored misunderstandings regarding fiber, probiotics, and specific food roles.
  • Revealed a significant gap between popular beliefs and scientific evidence.

Conclusions:

  • Community pharmacists are vital in dispelling constipation myths.
  • Evidence-based, personalized patient education is essential.
  • Addressing misconceptions improves constipation management and patient care.